Structure

Physi-Chem Properties

Molecular Weight:  568.27
Volume:  583.186
LogP:  4.221
LogD:  3.058
LogS:  -4.788
# Rotatable Bonds:  11
TPSA:  117.59
# H-Bond Aceptor:  9
# H-Bond Donor:  1
# Rings:  4
# Heavy Atoms:  9

MedChem Properties

QED Drug-Likeness Score:  0.184
Synthetic Accessibility Score:  5.477
Fsp3:  0.531
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.79
MDCK Permeability:  6.918372673681006e-05
Pgp-inhibitor:  0.833
Pgp-substrate:  0.024
Human Intestinal Absorption (HIA):  0.004
20% Bioavailability (F20%):  0.015
30% Bioavailability (F30%):  0.174

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.188
Plasma Protein Binding (PPB):  96.53511047363281%
Volume Distribution (VD):  1.511
Pgp-substrate:  9.340134620666504%

ADMET: Metabolism

CYP1A2-inhibitor:  0.111
CYP1A2-substrate:  0.118
CYP2C19-inhibitor:  0.716
CYP2C19-substrate:  0.169
CYP2C9-inhibitor:  0.726
CYP2C9-substrate:  0.809
CYP2D6-inhibitor:  0.668
CYP2D6-substrate:  0.495
CYP3A4-inhibitor:  0.868
CYP3A4-substrate:  0.467

ADMET: Excretion

Clearance (CL):  3.105
Half-life (T1/2):  0.485

ADMET: Toxicity

hERG Blockers:  0.002
Human Hepatotoxicity (H-HT):  0.85
Drug-inuced Liver Injury (DILI):  0.954
AMES Toxicity:  0.98
Rat Oral Acute Toxicity:  0.925
Maximum Recommended Daily Dose:  0.953
Skin Sensitization:  0.682
Carcinogencity:  0.745
Eye Corrosion:  0.021
Eye Irritation:  0.261
Respiratory Toxicity:  0.926

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC100420

Natural Product ID:  NPC100420
Common Name*:   Casearborin B
IUPAC Name:   [(1S,3R,5R,6aS,7R,8R,10aS)-1,3-diacetyloxy-7,8-dimethyl-7-[(2E)-3-methylpenta-2,4-dienyl]-1,3,5,6,6a,8,9,10-octahydrobenzo[d][2]benzofuran-5-yl] 4-hydroxy-3-methoxybenzoate
Synonyms:  
Standard InCHIKey:  HSCLLTPGIBCIBD-DZHOVOBOSA-N
Standard InCHI:  InChI=1S/C32H40O9/c1-8-18(2)11-13-31(6)19(3)12-14-32-24(29(38-20(4)33)41-30(32)39-21(5)34)16-23(17-27(31)32)40-28(36)22-9-10-25(35)26(15-22)37-7/h8-11,15-16,19,23,27,29-30,35H,1,12-14,17H2,2-7H3/b18-11+/t19-,23+,27+,29+,30-,31-,32-/m1/s1
SMILES:  C=C/C(=C/C[C@]1(C)[C@H](C)CC[C@@]23C(=C[C@@H](C[C@@H]12)OC(=O)c1ccc(c(c1)OC)O)[C@@H](OC(=O)C)O[C@H]3OC(=O)C)/C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL505172
PubChem CID:   5352095
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001551] Diterpenoids
          • [CHEMONTID:0001757] Colensane and clerodane diterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO28776 Casearia arborea Species Salicaceae Eukaryota n.a. n.a. n.a. PMID[10843580]
NPO28776 Casearia arborea Species Salicaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT390 Cell Line LOX IMVI Homo sapiens IC50 = 290.0 nM PMID[522552]
NPT374 Cell Line SF-539 Homo sapiens IC50 = 290.0 nM PMID[522552]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC100420 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9152 High Similarity NPC469438
0.9152 High Similarity NPC469354
0.9057 High Similarity NPC226759
0.9048 High Similarity NPC188217
0.9 High Similarity NPC68619
0.8976 High Similarity NPC316539
0.8974 High Similarity NPC162569
0.8974 High Similarity NPC35160
0.8961 High Similarity NPC208293
0.8909 High Similarity NPC202428
0.8909 High Similarity NPC266545
0.8902 High Similarity NPC200726
0.8869 High Similarity NPC475054
0.8869 High Similarity NPC469397
0.8868 High Similarity NPC62051
0.8861 High Similarity NPC267091
0.8861 High Similarity NPC124842
0.8854 High Similarity NPC267469
0.8854 High Similarity NPC87630
0.8854 High Similarity NPC179128
0.8854 High Similarity NPC116292
0.8848 High Similarity NPC177362
0.8831 High Similarity NPC469615
0.8797 High Similarity NPC243891
0.8795 High Similarity NPC21956
0.8774 High Similarity NPC469683
0.8758 High Similarity NPC471405
0.875 High Similarity NPC191046
0.875 High Similarity NPC194095
0.875 High Similarity NPC327032
0.8743 High Similarity NPC475299
0.8743 High Similarity NPC472803
0.8727 High Similarity NPC475738
0.8727 High Similarity NPC474301
0.872 High Similarity NPC41009
0.8704 High Similarity NPC4747
0.8704 High Similarity NPC472860
0.8704 High Similarity NPC104275
0.8696 High Similarity NPC10205
0.869 High Similarity NPC469773
0.869 High Similarity NPC469776
0.869 High Similarity NPC148185
0.869 High Similarity NPC469777
0.869 High Similarity NPC469778
0.869 High Similarity NPC135334
0.869 High Similarity NPC469774
0.869 High Similarity NPC469772
0.869 High Similarity NPC32723
0.869 High Similarity NPC100925
0.869 High Similarity NPC469775
0.869 High Similarity NPC295941
0.8688 High Similarity NPC61604
0.8688 High Similarity NPC245615
0.8688 High Similarity NPC299706
0.8688 High Similarity NPC115466
0.8671 High Similarity NPC96194
0.8671 High Similarity NPC299855
0.8667 High Similarity NPC100425
0.8659 High Similarity NPC477627
0.865 High Similarity NPC76211
0.865 High Similarity NPC179914
0.8625 High Similarity NPC36130
0.8625 High Similarity NPC134905
0.8621 High Similarity NPC189704
0.8614 High Similarity NPC180586
0.8606 High Similarity NPC476011
0.8606 High Similarity NPC145847
0.8599 High Similarity NPC320734
0.8599 High Similarity NPC258856
0.8598 High Similarity NPC239966
0.8598 High Similarity NPC203020
0.8596 High Similarity NPC80360
0.8596 High Similarity NPC469418
0.8596 High Similarity NPC260300
0.859 High Similarity NPC46880
0.8589 High Similarity NPC133984
0.8589 High Similarity NPC187205
0.858 High Similarity NPC156624
0.858 High Similarity NPC38699
0.858 High Similarity NPC172920
0.8571 High Similarity NPC476067
0.8571 High Similarity NPC137813
0.8571 High Similarity NPC157898
0.8571 High Similarity NPC44730
0.8571 High Similarity NPC475121
0.8563 High Similarity NPC469419
0.8555 High Similarity NPC473205
0.8555 High Similarity NPC473776
0.8554 High Similarity NPC45943
0.8554 High Similarity NPC109990
0.8554 High Similarity NPC120012
0.8553 High Similarity NPC478242
0.8547 High Similarity NPC195114
0.8547 High Similarity NPC108191
0.8547 High Similarity NPC93685
0.8545 High Similarity NPC469889
0.8544 High Similarity NPC24257
0.8544 High Similarity NPC153620
0.8538 High Similarity NPC473713
0.8538 High Similarity NPC79736
0.8538 High Similarity NPC67629
0.8537 High Similarity NPC160780
0.8537 High Similarity NPC469384
0.8537 High Similarity NPC289811
0.8528 High Similarity NPC109765
0.8528 High Similarity NPC163635
0.8528 High Similarity NPC228357
0.8512 High Similarity NPC311912
0.8509 High Similarity NPC478268
0.8509 High Similarity NPC203664
0.85 High Similarity NPC158635
0.85 High Similarity NPC12854
0.85 High Similarity NPC237441
0.85 High Similarity NPC205054
0.85 High Similarity NPC229882
0.8494 Intermediate Similarity NPC76687
0.8494 Intermediate Similarity NPC246024
0.8491 Intermediate Similarity NPC472969
0.8488 Intermediate Similarity NPC267549
0.8485 Intermediate Similarity NPC239818
0.8485 Intermediate Similarity NPC474936
0.8485 Intermediate Similarity NPC218471
0.8483 Intermediate Similarity NPC476358
0.8481 Intermediate Similarity NPC473867
0.8481 Intermediate Similarity NPC75295
0.848 Intermediate Similarity NPC193377
0.8476 Intermediate Similarity NPC202495
0.8476 Intermediate Similarity NPC286919
0.8476 Intermediate Similarity NPC1913
0.8476 Intermediate Similarity NPC475663
0.8462 Intermediate Similarity NPC88557
0.8457 Intermediate Similarity NPC131121
0.8457 Intermediate Similarity NPC308555
0.8452 Intermediate Similarity NPC469458
0.8452 Intermediate Similarity NPC88176
0.8452 Intermediate Similarity NPC130730
0.8452 Intermediate Similarity NPC469396
0.8452 Intermediate Similarity NPC301910
0.8452 Intermediate Similarity NPC469459
0.8452 Intermediate Similarity NPC149002
0.8447 Intermediate Similarity NPC118033
0.8438 Intermediate Similarity NPC476394
0.8438 Intermediate Similarity NPC98809
0.8438 Intermediate Similarity NPC111785
0.8434 Intermediate Similarity NPC266365
0.8434 Intermediate Similarity NPC293568
0.8434 Intermediate Similarity NPC117943
0.8434 Intermediate Similarity NPC472859
0.8434 Intermediate Similarity NPC216916
0.8434 Intermediate Similarity NPC311803
0.8434 Intermediate Similarity NPC25389
0.843 Intermediate Similarity NPC196771
0.8421 Intermediate Similarity NPC195972
0.8418 Intermediate Similarity NPC230670
0.8418 Intermediate Similarity NPC71385
0.8415 Intermediate Similarity NPC471968
0.8415 Intermediate Similarity NPC478055
0.8412 Intermediate Similarity NPC180768
0.8405 Intermediate Similarity NPC305710
0.8405 Intermediate Similarity NPC469888
0.8402 Intermediate Similarity NPC298847
0.8397 Intermediate Similarity NPC28398
0.8395 Intermediate Similarity NPC289438
0.8395 Intermediate Similarity NPC475579
0.8395 Intermediate Similarity NPC476434
0.8395 Intermediate Similarity NPC473773
0.8391 Intermediate Similarity NPC170203
0.8391 Intermediate Similarity NPC102367
0.8385 Intermediate Similarity NPC327962
0.8385 Intermediate Similarity NPC474305
0.8385 Intermediate Similarity NPC261322
0.8383 Intermediate Similarity NPC148273
0.8383 Intermediate Similarity NPC285108
0.8383 Intermediate Similarity NPC22130
0.8383 Intermediate Similarity NPC116838
0.8383 Intermediate Similarity NPC33298
0.8383 Intermediate Similarity NPC22324
0.8375 Intermediate Similarity NPC470757
0.8373 Intermediate Similarity NPC268718
0.8373 Intermediate Similarity NPC21046
0.8373 Intermediate Similarity NPC166277
0.8373 Intermediate Similarity NPC91634
0.8373 Intermediate Similarity NPC119125
0.8373 Intermediate Similarity NPC150943
0.8372 Intermediate Similarity NPC473630
0.8371 Intermediate Similarity NPC112708
0.8364 Intermediate Similarity NPC143328
0.8363 Intermediate Similarity NPC471181
0.8363 Intermediate Similarity NPC477617
0.8354 Intermediate Similarity NPC131532
0.8354 Intermediate Similarity NPC300757
0.8354 Intermediate Similarity NPC254163
0.8354 Intermediate Similarity NPC475484
0.8354 Intermediate Similarity NPC473090
0.8354 Intermediate Similarity NPC180901
0.8353 Intermediate Similarity NPC658
0.8353 Intermediate Similarity NPC117911
0.8353 Intermediate Similarity NPC197708
0.8344 Intermediate Similarity NPC310661
0.8344 Intermediate Similarity NPC105827

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC100420 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8547 High Similarity NPD8055 Clinical (unspecified phase)
0.8529 High Similarity NPD7685 Pre-registration
0.8424 Intermediate Similarity NPD6234 Discontinued
0.8302 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.8295 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.8294 Intermediate Similarity NPD3818 Discontinued
0.8294 Intermediate Similarity NPD7228 Approved
0.8232 Intermediate Similarity NPD37 Approved
0.8193 Intermediate Similarity NPD4966 Approved
0.8193 Intermediate Similarity NPD4967 Phase 2
0.8193 Intermediate Similarity NPD4965 Approved
0.8113 Intermediate Similarity NPD4628 Phase 3
0.8037 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.8 Intermediate Similarity NPD8127 Discontinued
0.8 Intermediate Similarity NPD8166 Discontinued
0.7989 Intermediate Similarity NPD7074 Phase 3
0.7976 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7939 Intermediate Similarity NPD7458 Discontinued
0.7931 Intermediate Similarity NPD7054 Approved
0.7919 Intermediate Similarity NPD7473 Discontinued
0.7886 Intermediate Similarity NPD7472 Approved
0.7877 Intermediate Similarity NPD8434 Phase 2
0.7853 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7849 Intermediate Similarity NPD6232 Discontinued
0.7812 Intermediate Similarity NPD7266 Discontinued
0.7809 Intermediate Similarity NPD8313 Approved
0.7809 Intermediate Similarity NPD8312 Approved
0.7802 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7797 Intermediate Similarity NPD7240 Approved
0.7791 Intermediate Similarity NPD7199 Phase 2
0.7784 Intermediate Similarity NPD7028 Phase 2
0.7753 Intermediate Similarity NPD7808 Phase 3
0.7727 Intermediate Similarity NPD5844 Phase 1
0.7701 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7697 Intermediate Similarity NPD6559 Discontinued
0.7697 Intermediate Similarity NPD7251 Discontinued
0.7692 Intermediate Similarity NPD1934 Approved
0.7661 Intermediate Similarity NPD3882 Suspended
0.7647 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7647 Intermediate Similarity NPD1465 Phase 2
0.764 Intermediate Similarity NPD6797 Phase 2
0.7622 Intermediate Similarity NPD6190 Approved
0.7616 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.761 Intermediate Similarity NPD230 Phase 1
0.7569 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.7564 Intermediate Similarity NPD9494 Approved
0.7561 Intermediate Similarity NPD4110 Phase 3
0.7561 Intermediate Similarity NPD4109 Clinical (unspecified phase)
0.7545 Intermediate Similarity NPD6273 Approved
0.7544 Intermediate Similarity NPD2801 Approved
0.7544 Intermediate Similarity NPD7819 Suspended
0.7542 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7529 Intermediate Similarity NPD5494 Approved
0.7528 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7514 Intermediate Similarity NPD7075 Discontinued
0.75 Intermediate Similarity NPD3817 Phase 2
0.7487 Intermediate Similarity NPD7680 Approved
0.7485 Intermediate Similarity NPD2532 Approved
0.7485 Intermediate Similarity NPD2533 Approved
0.7485 Intermediate Similarity NPD2534 Approved
0.746 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7458 Intermediate Similarity NPD6166 Phase 2
0.7458 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7458 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7456 Intermediate Similarity NPD1653 Approved
0.7442 Intermediate Similarity NPD8455 Phase 2
0.7427 Intermediate Similarity NPD6386 Approved
0.7427 Intermediate Similarity NPD6385 Approved
0.7421 Intermediate Similarity NPD3764 Approved
0.7394 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7374 Intermediate Similarity NPD7799 Discontinued
0.7368 Intermediate Similarity NPD4380 Phase 2
0.7358 Intermediate Similarity NPD5952 Clinical (unspecified phase)
0.7349 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7341 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.734 Intermediate Similarity NPD5619 Clinical (unspecified phase)
0.7329 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.7329 Intermediate Similarity NPD3620 Phase 2
0.731 Intermediate Similarity NPD3226 Approved
0.7306 Intermediate Similarity NPD7435 Discontinued
0.7297 Intermediate Similarity NPD8150 Discontinued
0.7296 Intermediate Similarity NPD8151 Discontinued
0.729 Intermediate Similarity NPD3705 Approved
0.7289 Intermediate Similarity NPD6674 Discontinued
0.7278 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7267 Intermediate Similarity NPD6599 Discontinued
0.7246 Intermediate Similarity NPD7003 Approved
0.7231 Intermediate Similarity NPD7999 Approved
0.7229 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7219 Intermediate Similarity NPD1511 Approved
0.7212 Intermediate Similarity NPD2935 Discontinued
0.72 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.72 Intermediate Similarity NPD5353 Approved
0.7197 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7189 Intermediate Similarity NPD8407 Phase 2
0.7184 Intermediate Similarity NPD6801 Discontinued
0.7178 Intermediate Similarity NPD6355 Discontinued
0.7172 Intermediate Similarity NPD7874 Approved
0.7172 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.716 Intermediate Similarity NPD6663 Approved
0.716 Intermediate Similarity NPD8032 Phase 2
0.715 Intermediate Similarity NPD6778 Approved
0.715 Intermediate Similarity NPD6782 Approved
0.715 Intermediate Similarity NPD6777 Approved
0.715 Intermediate Similarity NPD6776 Approved
0.715 Intermediate Similarity NPD6781 Approved
0.715 Intermediate Similarity NPD6779 Approved
0.715 Intermediate Similarity NPD6780 Approved
0.7143 Intermediate Similarity NPD3027 Phase 3
0.7143 Intermediate Similarity NPD5760 Phase 2
0.7143 Intermediate Similarity NPD9545 Approved
0.7143 Intermediate Similarity NPD5761 Phase 2
0.7143 Intermediate Similarity NPD3750 Approved
0.7143 Intermediate Similarity NPD8470 Clinical (unspecified phase)
0.7136 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7136 Intermediate Similarity NPD7783 Phase 2
0.7135 Intermediate Similarity NPD1512 Approved
0.7134 Intermediate Similarity NPD1608 Approved
0.7128 Intermediate Similarity NPD7696 Phase 3
0.7128 Intermediate Similarity NPD7698 Approved
0.7128 Intermediate Similarity NPD7697 Approved
0.7126 Intermediate Similarity NPD6873 Phase 2
0.7125 Intermediate Similarity NPD5736 Approved
0.712 Intermediate Similarity NPD6764 Approved
0.712 Intermediate Similarity NPD8368 Discontinued
0.712 Intermediate Similarity NPD6765 Approved
0.7114 Intermediate Similarity NPD7930 Approved
0.7111 Intermediate Similarity NPD5242 Approved
0.7108 Intermediate Similarity NPD2438 Suspended
0.7097 Intermediate Similarity NPD1357 Approved
0.7092 Intermediate Similarity NPD8319 Approved
0.7092 Intermediate Similarity NPD8320 Phase 1
0.7092 Intermediate Similarity NPD7870 Phase 2
0.7092 Intermediate Similarity NPD7871 Phase 2
0.7091 Intermediate Similarity NPD7097 Phase 1
0.7076 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7073 Intermediate Similarity NPD447 Suspended
0.7071 Intermediate Similarity NPD7701 Phase 2
0.7066 Intermediate Similarity NPD2346 Discontinued
0.7062 Intermediate Similarity NPD7768 Phase 2
0.705 Intermediate Similarity NPD7801 Approved
0.7048 Intermediate Similarity NPD2799 Discontinued
0.7044 Intermediate Similarity NPD8404 Phase 2
0.7044 Intermediate Similarity NPD1283 Approved
0.7037 Intermediate Similarity NPD7095 Approved
0.7029 Intermediate Similarity NPD7411 Suspended
0.7027 Intermediate Similarity NPD7039 Approved
0.7027 Intermediate Similarity NPD7038 Approved
0.7025 Intermediate Similarity NPD3972 Approved
0.7018 Intermediate Similarity NPD6799 Approved
0.7012 Intermediate Similarity NPD2979 Phase 3
0.7012 Intermediate Similarity NPD4060 Phase 1
0.7012 Intermediate Similarity NPD4140 Approved
0.7011 Intermediate Similarity NPD3455 Phase 2
0.7011 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7006 Intermediate Similarity NPD5402 Approved
0.7006 Intermediate Similarity NPD6100 Approved
0.7006 Intermediate Similarity NPD6099 Approved
0.7 Intermediate Similarity NPD6959 Discontinued
0.6995 Remote Similarity NPD3751 Discontinued
0.699 Remote Similarity NPD6823 Phase 2
0.6983 Remote Similarity NPD919 Approved
0.6983 Remote Similarity NPD5537 Clinical (unspecified phase)
0.6982 Remote Similarity NPD2800 Approved
0.6978 Remote Similarity NPD7852 Clinical (unspecified phase)
0.6977 Remote Similarity NPD4378 Clinical (unspecified phase)
0.697 Remote Similarity NPD1933 Approved
0.6968 Remote Similarity NPD6785 Approved
0.6968 Remote Similarity NPD6784 Approved
0.6964 Remote Similarity NPD2343 Clinical (unspecified phase)
0.6964 Remote Similarity NPD5762 Approved
0.6964 Remote Similarity NPD5763 Approved
0.6961 Remote Similarity NPD5710 Approved
0.6961 Remote Similarity NPD7229 Phase 3
0.6961 Remote Similarity NPD5711 Approved
0.6959 Remote Similarity NPD7699 Phase 2
0.6959 Remote Similarity NPD7700 Phase 2
0.6959 Remote Similarity NPD7236 Approved
0.6954 Remote Similarity NPD7497 Discontinued
0.6952 Remote Similarity NPD3534 Clinical (unspecified phase)
0.6946 Remote Similarity NPD1510 Phase 2
0.6943 Remote Similarity NPD17 Approved
0.6941 Remote Similarity NPD1878 Clinical (unspecified phase)
0.6927 Remote Similarity NPD3749 Approved
0.6923 Remote Similarity NPD3926 Phase 2
0.6923 Remote Similarity NPD1549 Phase 2
0.6918 Remote Similarity NPD9269 Phase 2
0.6911 Remote Similarity NPD2488 Approved
0.6911 Remote Similarity NPD2490 Approved
0.6909 Remote Similarity NPD7966 Clinical (unspecified phase)
0.6908 Remote Similarity NPD7907 Approved
0.6904 Remote Similarity NPD2491 Approved
0.6904 Remote Similarity NPD3057 Approved
0.6891 Remote Similarity NPD6534 Approved
0.6891 Remote Similarity NPD6535 Approved
0.689 Remote Similarity NPD6798 Discontinued
0.689 Remote Similarity NPD6859 Clinical (unspecified phase)
0.6888 Remote Similarity NPD4107 Approved
0.6875 Remote Similarity NPD7296 Approved
0.6872 Remote Similarity NPD4420 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data